Stay updated with breaking news from Sight Sciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
13.09.2022 - 310-patient RCT designed to evaluate the superiority of TearCare (device) vs Restasis (drug) in patients with chronic dry eye disease is now fully enrolled6-Month efficacy results expected by Summer 2023 MENLO PARK, Calif., Sept. 13, 2022 ... Seite 1
02.09.2022 - MENLO PARK, Calif., Sept. 02, 2022 (GLOBE NEWSWIRE) - Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced plans to ...
SGHT earnings call for the period ending June 30, 2022.
MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative...
Sight Sciences is seeing rapid revenue growth and over half of its market cap is net cash. Why am I still not enthusiastic about SGHT stock? Find out.